A molecular revolution in uveal melanoma: implications for patient care and targeted therapy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Ophthalmology (Rochester, Minn.)

• Publication date

  2014-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ophtha.2013.12.014PMID 24480708PMCID PMC4047132
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile.

  2014cited by this paper
• The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma

  2013cited by this paper
• Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma

  2013cited by this paper
• Simultaneous Identification of Multiple Driver Pathways in Cancer

  2013cited by this paper
• Clinical activity of ipilimumab for metastatic uveal melanoma

  2013cited by this paper
• Selumetinib shows promise in metastatic uveal melanoma.

  2013cited by this paper
• BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma

  2013cited by this paper
• Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3

  2013cited by this paper
• Genomic, prognostic, and cell-signaling advances in uveal melanoma.

  2013cited by this paper
• Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11-Dependent Manner

  2012cited by this paper
• ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression.

  2012cited by this paper
• Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines

  2012cited by this paper
• The genetics of uveal melanoma: an emerging framework for targeted therapy

  2012cited by this paper
• Collaborative Ocular Oncology Group Report No. 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma

  2012cited by this paper
• Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.

  2012cited by this paper
• A pilot study of sunitinib malate in patients with metastatic uveal melanoma

  2012cited by this paper
• BAP1 loss defines a new class of renal cell carcinoma

  2012cited by this paper
• BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs

  2012cited by this paper
• An Emerging Model for BAP1’s Role in Regulating Cell Cycle Progression

  2011cited by this paper
• Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma

  2011cited by this paper
• Germline mutations in BAP1 predispose to melanocytic tumors

  2011cited by this paper
• Germline BAP1 mutations predispose to malignant mesothelioma

  2011cited by this paper
• Therapeutic Implications of the Emerging Molecular Biology of Uveal Melanoma

  2011cited by this paper
• Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers

  2011cited by this paper
• Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

  2010influential reference
• Genotypic Profiling of 452 Choroidal Melanomas with Multiplex Ligation-Dependent Probe Amplification

  2010cited by this paper
• Inhibition of mutated, activated BRAF in metastatic melanoma.

  2010cited by this paper
• Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB

  2010cited by this paper
• Mutations in GNA11 in uveal melanoma.

  2010influential reference
• Effectiveness of treatments for metastatic uveal melanoma.

  2009cited by this paper
• Hepatic metastasis from uveal melanoma: angiographic pattern predictive of survival after hepatic arterial chemoembolization.

  2009cited by this paper
• Hepatic arterial chemoembolization for management of metastatic melanoma.

  2008cited by this paper
• Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.

  2008cited by this paper
• Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases

  2008cited by this paper
• Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi

  2008cited by this paper
• Oncogenic mutations in GNAQ occur early in uveal melanoma.

  2008cited by this paper
• Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis

  2008cited by this paper
• The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies.

  2007cited by this paper
• Transcriptomic versus Chromosomal Prognostic Markers and Clinical Outcome in Uveal Melanoma

  2007cited by this paper
• Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.

  2006cited by this paper
• Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS

  2005cited by this paper
• Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas.

  2005cited by this paper
• Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death

  2004cited by this paper
• Survival rates with uveal melanoma in the United States: 1973-1997.

  2003cited by this paper
• Absence of Mutations of the BRAF Gene and Constitutive Activation of Extracellular-Regulated Kinase in Malignant Melanomas of the Uvea

  2003cited by this paper
• Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities.

  2003cited by this paper
• Familial uveal melanoma.

  1988cited by this paper

• AIBI Modified Mesoporous Copper Sulfide Nanocomposites for Efficient Non-Oxygen Dependent Free Radicals-Assisted Photothermal Therapy in Uveal Melanoma.

  2024cites this paper
• Recent Advances in Molecular and Genetic Research on Uveal Melanoma

  2024cites this paper
• Small Choroidal Melanoma: Outcomes Following Surveillance vs Immediate Treatment.

  2022cites this paper
• Fine Needle Aspiration Biopsy for Intraocular Tumors: Why and When

  2022cites this paper
• PRRX1 Is a Novel Prognostic Biomarker and Facilitates Tumor Progression Through Epithelial–Mesenchymal Transition in Uveal Melanoma

  2022cites this paper
• Advances in the treatment of intraocular malignancies: A literature review

  2022cites this paper
• What’s in a Name? Large Choroidal Nevus, Small Choroidal Melanoma, or Indeterminate Melanocytic Tumor

  2021cites this paper
• Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth

  2021cites this paper
• Targeted therapy for malignant ocular melanomas

  2021influential citation
• Sinusoidal Growth Pattern of Hepatic Melanoma Metastasis

  2021cites this paper
• Focal Aggregates of Normal or Near Normal Uveal Melanocytes (FANNUMs) in the Choroid. A Practical Clinical Category of Small Ophthalmoscopically Evident Discrete Melanocytic Choroidal Lesions

  2021cites this paper
• Epigenetics in ocular medicine

  2021cites this paper
• Uveal Melanoma: Genetics and Clinical Prognostication

  2021cites this paper
• Uveal Melanoma – Standardised Procedure in Diagnosis, Therapy and Surveillance Das uveale Melanom – standardisiertes Vorgehen in Diagnostik, Therapie und Nachsorge

  2021cites this paper
• Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma

  2021cites this paper
• The Trends of Uveal Melanoma Research in the Past Two Decades and Future Perspectives

  2021cites this paper
• Ocular Tumors

  2020cites this paper
• Uveal Melanoma-Derived Extracellular Vesicles Display Transforming Potential and Carry Protein Cargo Involved in Metastatic Niche Preparation

  2020cites this paper
• Diabetic Retinopathy and Ocular Melanoma: How Far We Are?

  2020cites this paper
• Identification of differentially expressed metastatic genes and their signatures to predict the overall survival of uveal melanoma patients by bioinformatics analysis.

  2020cites this paper
• Towards Liver: Selected Aspects of Uveal Melanoma Metastasis

  2020cites this paper
• Ocular Melanocytic Tumors

  2020cites this paper
• Ocular cytology: Diagnostic features and ongoing practices

  2020cites this paper
• Uveal melanoma: progress in molecular biology and therapeutics

  2020cites this paper
• Molecular Diagnostics in Melanoma: An Update

  2019cites this paper
• Indications for Fine Needle Aspiration Biopsy of Posterior Segment Intraocular Tumors.

  2019cites this paper
• Clinical spectrum, treatment and outcomes of uveal melanoma in a tertiary centre.

  2019cites this paper
• BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas

  2019cites this paper
• Molekulares Tumorboard beim Melanom

  2019cites this paper
• Are Risk Factors for Growth of Choroidal Nevi Associated With Malignant Transformation? Assessment With a Validated Genomic Biomarker.

  2019cites this paper
• Potential Mutations in Uveal Melanoma Identified Using Targeted Next-Generation Sequencing

  2019cites this paper
• Clinical predictors of survival in metastatic uveal melanoma

  2019cites this paper
• Role of epigenetic deregulation in hematogenous dissemination of malignant uveal melanoma Minireview

  2018cites this paper
• Do Largest Basal Tumor Diameter and the American Joint Committee on Cancer's Cancer Staging Influence Prognostication by Gene Expression Profiling in Choroidal Melanoma.

  2018cites this paper
• Intraocular biopsy of uveal melanoma Risk assessment and identification of genetic prognostic markers

  2018cites this paper
• Tumour Expression of Histone Deacetylases in Uveal Melanoma

  2018cites this paper
• Ocular Cancer Biomarkers, Mutation Profiles, and Therapeutic Strategies

  2018cites this paper
• Punctuated evolution of canonical genomic aberrations in uveal melanoma

  2018cites this paper
• Tele-Oncology: A Validation Study of Choroidal and Iris Nevi

  2018cites this paper
• Gene Expression Profiling as an Adjunctive Measure to Guide the Management of Indeterminate, High-Risk Choroidal Melanocytic Lesions: A Pilot Study

  2018cites this paper
• Primary Cutaneous Melanocytic Neoplasms

  2018cites this paper
• Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma

  2018cites this paper
• Ulcerative Keratitis

  2018cites this paper
• Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma

  2018cites this paper
• Xenograft Mouse Model of Human Uveal Melanoma.

  2017cites this paper
• Dysregulated GPCR Signaling and Therapeutic Options in Uveal Melanoma

  2017cites this paper
• Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma

  2017cites this paper
• Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis

  2017cites this paper
• PRL‐3/PTP4A3 phosphatase regulates integrin &bgr;1 in adhesion structures during migration of human ocular melanoma cells

  2017cites this paper
• Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit.

  2017cites this paper
• Prognostic Factors and Decision Tree for Long-Term Survival in Metastatic Uveal Melanoma

  2017cites this paper
• Uveal Melanoma: GNAQ and GNA11 Mutations in a Greek Population.

  2017cites this paper
• Liquid Biopsy in Retinoblastoma.

  2017cites this paper
• Genetic markers in circulating tumour cells as a measure of the metastatic propensity of uveal melanoma

  2017influential citation
• Epigenetics in Ocular Medicine

  2016cites this paper
• Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the surveillance, epidemiology, and end results database (1973–2012)

  2016cites this paper
• Resección transescleral combinada versus Braquiterapia con yodo 125 en el tratamiento primario del melanoma de coroides

  2016cites this paper
• The impact of sequencing on diagnosis and treatment of malignant melanoma

  2016influential citation
• Gene of the month: BAP1

  2016cites this paper
• Assessing Prognosis in Uveal Melanoma.

  2016cites this paper
• Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the surveillance, epidemiology, and end results database (1973–2012)

  2016cites this paper
• Long-Term Progression-Free and Overall Survival in Two Melanoma Patients Treated with Patient-Specific Therapeutic Vaccine Eltrapuldencel-T After Resection of a Solitary Liver Metastasis

  2016cites this paper
• Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).

  2016cites this paper
• Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973–2012)

  2016cites this paper
• Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the surveillance, epidemiology, and end results database (1973–2012)

  2016cites this paper
• Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases

  2016cites this paper
• Histopathologic and mutational analysis of a case of blue nevus‐like melanoma

  2016cites this paper
• Mutation analysis of metastatic melanomas in the central nervous system: results of a panel of 5 genes in 48 cases.

  2016cites this paper
• PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma

  2016cites this paper
• Low thyroid hormone levels improve survival in murine model for ocular melanoma

  2015cites this paper
• Quantitative Proteomic Analysis and Gene Expression Profiling Microarray Re-analysis of Uveal Melanoma

  2015cites this paper
• Study of the Role of Circulating Tumor Cells (CTC) and Circulating Cellular Microenvironment Components in Metastasis Formation and their Clinical Value

  2015cites this paper
• Predicting the outcome of melanoma: can we tell the future of a patient's melanoma?

  2015cites this paper
• Potential Role of Soluble c-Met as a New Candidate Biomarker of Metastatic Uveal Melanoma.

  2015cites this paper
• Management of posterior uveal melanoma: past, present, and future: the 2014 Charles L. Schepens lecture.

  2015cites this paper
• Inferring an Evolutionary Tree of Uveal Melanoma From Genomic Copy Number Aberrations.

  2015influential citation
• Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation

  2015cites this paper
• Variable Results for Uveal Melanoma-Specific Gene Expression Profile Prognostic Test in Choroidal Metastasis.

  2015cites this paper
• International Validation of the American Joint Committee on Cancer's 7th Edition Classification of Uveal Melanoma.

  2015cites this paper
• Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).

  2015cites this paper
• Diagnostic value of SOX-10 immunohistochemical staining for the detection of uveal melanoma

  2015cites this paper
• Improving risk estimates of metastasis from uveal melanoma through mutation profiling.

  2014cites this paper
• Recent developments in prognostic and predictive testing in uveal melanoma

  2014cites this paper
• The Application of Clinical Genetics Dovepress the Genetics of Uveal Melanoma: Current Insights

  year unknowncites this paper
• Clinical Ophthalmology Dovepress

  year unknowncites this paper